Molecular analysis of the FHIT gene at 3p14.2 in lung cancer cell lines

被引:0
|
作者
Yanagisawa, K
Kondo, M
Osada, H
Uchida, K
Takagi, K
Masuda, A
Takahashi, T
Takahashi, T
机构
[1] AICHI CANC CTR,RES INST,LAB ULTRASTRUCT RES,NAGOYA,AICHI 464,JAPAN
[2] AICHI CANC CTR,RES INST,IMMUNOL LAB,NAGOYA,AICHI 464,JAPAN
[3] NAGOYA UNIV,SCH MED,DEPT INTERNAL MED 2,SHOWA KU,NAGOYA,AICHI 466,JAPAN
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Chromosome 3p is frequently deleted in various cancers including examples in the lung. A novel gene, termed FHIT, was recently isolated from the fragile site at 3p14.2, with aberrant transcripts being reported in lung cancer tumor specimens. To avoid overlooking tumor-specific altered transcripts due to contaminating normal cells in primary tumors, FHIT alterations were examined in 41 lung cancer cell lines in the present study. Lack of detectable expression or exclusive expression of aberrantly spliced transcripts, often accompanied by intragenic homozygous deletions, were observed in 7 of 24 non-small cell lung cancers (29%) but in 0 of 17 small cell lung cancers (0%). Extensive reverse transcription-PCR-single-strand conformation polymorphism analysis revealed polymorphisms and alternative splicing but failed to identify point mutations. These results suggest distinct mechanisms for FHIT alterations in lung tumorigenesis and that further studies of this interesting gene are warranted.
引用
收藏
页码:5579 / 5582
页数:4
相关论文
共 50 条
  • [1] The FHIT gene at 3p14.2 is abnormal in lung cancer
    Sozzi, G
    Veronese, ML
    Negrini, M
    Baffa, R
    Cotticelli, MG
    Inoue, H
    Tornielli, S
    Pilotti, S
    DeGregorio, L
    Pastorino, U
    Pierotti, MA
    Ohta, M
    Huebner, K
    Croce, CM
    [J]. CELL, 1996, 85 (01) : 17 - 26
  • [2] The FHIT gene at 3p14.2 is abnormal in breast carcinomas
    Negrini, M
    Monaco, C
    Vorechovsky, I
    Ohta, M
    Druck, T
    Baffa, R
    Huebner, K
    Croce, CM
    [J]. CANCER RESEARCH, 1996, 56 (14) : 3173 - 3179
  • [3] Frequent abnormalities of the putative tumor suppressor gene FHIT at 3p14.2 in pancreatic carcinoma cell lines
    Simon, B
    Bartsch, D
    Barth, P
    Prasnikar, N
    Münch, K
    Blum, A
    Arnold, R
    Göke, B
    [J]. CANCER RESEARCH, 1998, 58 (08) : 1583 - 1587
  • [4] Contig array CGH at 3p14.2 points to the FHIT gene as the deleted gene in diffuse large B cell lymphoma
    Kameoka, Y
    Tagawa, H
    Tsuzuki, S
    Ota, A
    Suzuki, R
    Seto, M
    [J]. BLOOD, 2004, 104 (11) : 431A - 432A
  • [5] Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene
    Zimonjic, DB
    Druck, T
    Ohta, M
    Kastury, K
    Croce, CM
    Popescu, NC
    Huebner, K
    [J]. CANCER RESEARCH, 1997, 57 (06) : 1166 - 1170
  • [6] Loss of heterozygosity at 3p14.2 in clear cell renal cell carcinoma is an early event and is highly localized to the FHIT gene locus
    Velickovic, M
    Delahunt, B
    Grebe, SKG
    [J]. CANCER RESEARCH, 1999, 59 (06) : 1323 - 1326
  • [7] The putative tumor suppressor gene FHIT at 3p14.2 is rarely deleted in primary human brain tumors
    Frank, S
    Muller, J
    Plaschke, J
    Schackert, G
    Schackert, H
    [J]. 11TH INTERNATIONAL CONGRESS OF NEUROLOGICAL SURGERY, VOLS 1 AND 2, 1997, : 1723 - 1727
  • [8] MOLECULAR CHARACTERIZATION OF THE 3P14.2 CONSTITUTIVE FRAGILE SITE
    PARADEE, W
    WANG, N
    JAYASANKAR, V
    MULLINS, C
    WILKE, C
    GLOVER, TW
    SMITH, DI
    [J]. CYTOGENETICS AND CELL GENETICS, 1995, 68 (3-4): : 143 - 143
  • [9] Loss of FHIT expression in non-small-cell lung carcinomas: Correlation with loss of heterozygosity (LOH) at 3p14.2 and other molecular and clinical features.
    Toledo, G
    Sola, I
    Lozano, MD
    Soria, E
    Torre, W
    Pardo, FJ
    [J]. MODERN PATHOLOGY, 2001, 14 (01) : 227A - 227A
  • [10] Loss of FHIT expression in non-small-cell lung carcinomas: Correlation with loss of heterozygosity (LOH) at 3p14.2 and other molecular and clinical features.
    Toledo, G
    Sola, I
    Lozano, MD
    Soria, E
    Torre, W
    Pardo, FJ
    [J]. LABORATORY INVESTIGATION, 2001, 81 (01) : 227A - 227A